Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of life
- PMID: 8781565
- PMCID: PMC12201398
- DOI: 10.1007/BF01213547
Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of life
References
-
- Alberts DS, Noel JK (1995) Cisplatin-associated neurotoxicity: can it be prevented? Anti-Cancer Drugs 6: 369–383 - PubMed
-
- Chaudhry V, Rowinsky EJ, Sartorius SE, Donehower RC, Cornblath DR (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35: 304–311 - PubMed
-
- Connelly B, Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1996) Paclitaxel delivered as a 3 hour infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol Oncol (in press) - PubMed
-
- McGuire WP, Hoskins WJ, Brady MF, Kucerta PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med 334: 1–6 - PubMed
-
- Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207–214 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical